Company registration number 11897355 (England and Wales)
SDH MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
SDH MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
SDH MEDICAL LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
15,780
32,910
Tangible assets
4
4,447
409
Investments
5
25,752
25,723
45,979
59,042
Current assets
Debtors
6
795
2,271
Cash at bank and in hand
54,589
39,508
55,384
41,779
Creditors: amounts falling due within one year
7
(7,504)
(11,638)
Net current assets
47,880
30,141
Total assets less current liabilities
93,859
89,183
Provisions for liabilities
(439)
(78)
Net assets
93,420
89,105
Capital and reserves
Called up share capital
8
30
30
Revaluation reserve
-
0
7,812
Profit and loss reserves
93,390
81,263
Total equity
93,420
89,105

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

SDH MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on
22 December 2025
22 December 2025
and are signed on its behalf by:
Dr D V Hetherington
Dr S L Hetherington
Director
Director
Company registration number 11897355 (England and Wales)
SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

SDH Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is C/O Rmt Accountants & Business Advisors Ltd, Gosforth Park Avenue, Newcastle Upon Tyne, United Kingdom, NE12 8EG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for medical services.

 

Revenue is recognised when the services are delivered to clients, in line with the client agreement and the entitlement to income.

1.3
Intangible fixed assets other than goodwill

Cryptographic intangible assets are recognised at cost and are subsequently measured at fair value less accumulated amortisation and impairment losses.

Intangible assets comprise primarily cryptocurrency, such assets are defined as having indefinite useful lives and are therefore not amortised but tested annually for impairment.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% straight line
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.10
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Total
2
2
3
Intangible fixed assets
Crypto - currency
£
Cost
At 1 April 2024
37,817
Additions
175,271
Disposals
(184,636)
Revaluation
(9,933)
At 31 March 2025
18,519
Amortisation and impairment
At 1 April 2024
4,907
Impairment losses
95
Reversal of past impairment loss
(2,263)
At 31 March 2025
2,739
Carrying amount
At 31 March 2025
15,780
At 31 March 2024
32,910
SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
4
Tangible fixed assets
Computers
£
Cost
At 1 April 2024
1,778
Additions
5,189
Disposals
(1,318)
At 31 March 2025
5,649
Depreciation
At 1 April 2024
1,369
Depreciation charged in the year
1,151
Eliminated in respect of disposals
(1,318)
At 31 March 2025
1,202
Carrying amount
At 31 March 2025
4,447
At 31 March 2024
409
SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
5
Fixed asset investments
2025
2024
£
£
Other investments other than loans
25,752
25,723
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2024
25,723
Additions
24,037
Valuation changes
(576)
Disposals
(23,432)
At 31 March 2025
25,752
Carrying amount
At 31 March 2025
25,752
At 31 March 2024
25,723
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
795
2,271
7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
2,406
7,024
Other creditors
2,578
2,214
Accruals and deferred income
2,520
2,400
7,504
11,638
8
Called up share capital
2025
2024
Ordinary share capital
£
£
Issued and fully paid
A ordinary of £1 each
12
12
B ordinary of £1 each
12
12
C ordinary of £1 each
6
6
30
30
SDH MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
9
Related party transactions

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due to related parties
£
£
Directors
2,578
2,214

There are no set terms as to the repayment of this balance and no interest accrued thereon.

2025-03-312024-04-01falsefalsefalse22 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityDr D V HetheringtonDr S L Hetherington118973552024-04-012025-03-31118973552025-03-31118973552024-03-3111897355core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2025-03-3111897355core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-03-3111897355core:ComputerEquipment2025-03-3111897355core:ComputerEquipment2024-03-3111897355core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3111897355core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111897355core:CurrentFinancialInstruments2025-03-3111897355core:CurrentFinancialInstruments2024-03-3111897355core:ShareCapital2025-03-3111897355core:ShareCapital2024-03-3111897355core:RevaluationReserve2025-03-3111897355core:RevaluationReserve2024-03-3111897355core:RetainedEarningsAccumulatedLosses2025-03-3111897355core:RetainedEarningsAccumulatedLosses2024-03-3111897355core:ShareCapitalOrdinaryShareClass12025-03-3111897355core:ShareCapitalOrdinaryShareClass12024-03-3111897355core:ShareCapitalOrdinaryShareClass22025-03-3111897355core:ShareCapitalOrdinaryShareClass22024-03-3111897355core:ShareCapitalOrdinaryShareClass32025-03-3111897355core:ShareCapitalOrdinaryShareClass32024-03-3111897355core:ShareCapitalOrdinaryShares2025-03-3111897355core:ShareCapitalOrdinaryShares2024-03-3111897355bus:Director12024-04-012025-03-3111897355bus:Director22024-04-012025-03-3111897355core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111897355core:ComputerEquipment2024-04-012025-03-31118973552023-04-012024-03-3111897355core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-03-3111897355core:Non-standardIntangibleAssetClass1ComponentIntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111897355core:ComputerEquipment2024-03-3111897355bus:OrdinaryShareClass12024-04-012025-03-3111897355bus:OrdinaryShareClass22024-04-012025-03-3111897355bus:OrdinaryShareClass32024-04-012025-03-3111897355bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111897355bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3111897355bus:FRS1022024-04-012025-03-3111897355bus:AuditExemptWithAccountantsReport2024-04-012025-03-3111897355bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP